Key Insights

Highlights

Treatment Research

9 treatments under study, led by Nacl 09 Placebo

Related Conditions

Often studied with 7 related conditions

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 50/100

Termination Rate

0.0%

0 terminated out of 4 trials

Late-Stage Pipeline

0%

0 trials in Phase 3/4

Results Transparency

0%

0 of 0 completed with results

Key Signals

Data Visualizations

Phase Distribution

3Total
Not Applicable (2)
Phase 2 (1)

Trial Status

Unknown3
Not Yet Recruiting1

Clinical Trials (4)

Showing 4 of 4 trials
NCT06742255Not Yet RecruitingPrimary

Stellate Ganglion Block in Longstanding Facial Nerve Palsy Patients

NCT06112392Not ApplicableUnknownPrimary

Clinical Study of Stellate Ganglion Block in Treatment of Patients With Advanced Primary Parkinson's Disease

NCT06033456Not ApplicableUnknownPrimary

Combining Stellate Ganglion and T2 and T3 Radiofrequency Ablation on Post-mastectomy Complex Regional Pain Syndrome

NCT02732093Phase 2Unknown

Does Stellate Ganglion Block Decrease Stress Response of Intubation?

Showing all 4 trials

Research Network

Common Treatments

  • Nacl 09 Placebo1
  • Lidocaine1
  • Stellate Block1
  • Radiofrequency Stellate Ganglion Block Using Ultrasound Guidance Sgb1
  • Stellate Ganglion Block1

Active Sponsors

  • Assiut University2
  • National Cancer Institute, Egypt1
  • Zhujiang Hospital1

Top Investigators

Related Conditions

  • Pain Management1
  • Parkinson Disease1
  • Facial Palsy1
  • Mastectomy1
  • Radiofrequency Ablation1

Activity Timeline